Dr. Yang is involved in the clinical and scientific study of T-cell adoptive therapy and other immunotherapies to treat melanoma and other cancers. He is particularly interested in expanding these modalities to other cancers such as renal, lung and thyroid cancer and is initiating these clinical protocols. His laboratory efforts have concentrated on the development of novel antigen receptors for T-cells with optimized specificity and efficacy in treating cancers.